Lysergide

This classification denotes a serotonin antagonist and serotonin agonist with the molecular formula C20H25N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8NA5SWF92O, chemically known as d-lysergic acid n,n-diethylamide but generally known as lysergide, which bears US NIH Compound Identifier 3981. European Medicines Agency schedules Lysergide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08628MIG. The term LYSERGIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). LYSERGIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lysergide under HS 29396900 and SITC 54146. As of Q4 2014, LYSERGIDE remains the US FDA Preferred Term for this commodity. Lysergide bears US NLM identifiers UMLS ID C0024334 and NCI Concept Code C76104. SMILES: O=C(N(CC)CC)C1CN(C2C(=C1)c1c3c(C2)c[nH]c3ccc1)C.